Evidence map›Paper›PMID 32179496›Full record

ArticleEBioMedicine2020

Response to "High CD44 expression is not a prognosis marker in patients with high-risk neuroblastoma".

Francisco M Vega, Ana Colmenero-Repiso, María A Gómez-Muñoz, Ismael Rodríguez-Prieto, Diana Aguilar-Morante, Gema Ramírez, Catalina Márquez, Rosa Cabello, Ricardo Pardal

Abstract readComment
PubMed Full text at PMC Publisher
In one paragraph

Article in EBioMedicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Francisco M VegaDpto. de Biología Celular, Universidad de Sevilla and Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Reina Mercedes 6, 41012 Seville, Spain. Electronic address: fmvega@us.es.
Ana Colmenero-RepisoInstituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla and Dpto. de Fisiología Médica y Biofísica, Universidad de Sevilla, IBiS. Avda. Manuel Siurot s/n, 41013 Seville, Spain.
María A Gómez-MuñozInstituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla and Dpto. de Fisiología Médica y Biofísica, Universidad de Sevilla, IBiS. Avda. Manuel Siurot s/n, 41013 Seville, Spain.
Ismael Rodríguez-PrietoInstituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla and Dpto. de Fisiología Médica y Biofísica, Universidad de Sevilla, IBiS. Avda. Manuel Siurot s/n, 41013 Seville, Spain.
Diana Aguilar-MoranteInstituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla and Dpto. de Fisiología Médica y Biofísica, Universidad de Sevilla, IBiS. Avda. Manuel Siurot s/n, 41013 Seville, Spain.
Gema RamírezUnidad de Oncología Pediátrica. Hospital Universitario Virgen del Rocío, Spain.
Catalina MárquezUnidad de Oncología Pediátrica. Hospital Universitario Virgen del Rocío, Spain.
Rosa CabelloUnidad de Cirugía Pediátrica, Hospital Universitario Virgen del Rocío, Spain.
Ricardo PardalInstituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla and Dpto. de Fisiología Médica y Biofísica, Universidad de Sevilla, IBiS. Avda. Manuel Siurot s/n, 41013 Seville, Spain. Electronic address: rpardal@us.es.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Hyaluronan ReceptorsNeuroblastomaHumansPrognosisCD44 protein, humanHyaluronan ReceptorsCD44 expressionNeuroblastomaSurvivalUndifferentiation

Identifiers

PMID32179496
PMCPMC7078286

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.